CABODI, Sara
 Distribuzione geografica
Continente #
NA - Nord America 3.202
EU - Europa 1.920
AS - Asia 883
AF - Africa 35
SA - Sud America 19
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.076
Nazione #
US - Stati Uniti d'America 3.158
CN - Cina 590
IT - Italia 497
SE - Svezia 239
DE - Germania 190
IE - Irlanda 181
FR - Francia 175
FI - Finlandia 109
AT - Austria 108
UA - Ucraina 101
KR - Corea 93
GB - Regno Unito 92
PL - Polonia 67
VN - Vietnam 52
JP - Giappone 50
DK - Danimarca 48
CA - Canada 42
BE - Belgio 38
SN - Senegal 28
SG - Singapore 26
IN - India 19
NL - Olanda 18
RU - Federazione Russa 17
SA - Arabia Saudita 14
TW - Taiwan 13
AU - Australia 12
HK - Hong Kong 12
BR - Brasile 11
CH - Svizzera 11
ES - Italia 6
CL - Cile 5
EU - Europa 4
PT - Portogallo 4
AR - Argentina 3
CZ - Repubblica Ceca 3
GR - Grecia 3
IR - Iran 3
NO - Norvegia 3
PK - Pakistan 3
DZ - Algeria 2
ET - Etiopia 2
MX - Messico 2
MY - Malesia 2
NG - Nigeria 2
RO - Romania 2
TH - Thailandia 2
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
IS - Islanda 1
KE - Kenya 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.076
Città #
Chandler 468
Beijing 320
Fairfield 309
Ann Arbor 206
Dublin 179
Ashburn 172
Houston 158
Woodbridge 153
Seattle 134
Torino 129
Wilmington 126
Vienna 106
Pisa 90
Cambridge 84
Villeurbanne 78
Nyköping 76
Warsaw 64
Jacksonville 63
Medford 56
Dearborn 55
Princeton 53
Fremont 42
Shanghai 39
Turin 39
Brussels 35
Dong Ket 34
New York 32
Redwood City 27
Boston 26
Milan 23
Toronto 23
Boardman 22
Nanjing 22
Guangzhou 20
San Diego 19
Seongnam 16
Phoenix 15
Düsseldorf 13
Munich 13
Seoul 11
Tokyo 11
Chicago 10
Fuzhou 10
Los Angeles 10
Perugia 10
Silver Spring 10
Taipei 10
Hefei 9
Norwalk 9
Washington 9
Brignano Gera d'Adda 8
Jinan 8
Kunming 8
Lachine 8
London 8
Verona 8
Xian 8
Helsinki 7
Shenyang 7
Singapore 7
Wuhan 7
Chengdu 6
Chongqing 6
Copenhagen 6
Falls Church 6
Montpellier 6
Philadelphia 6
Zhengzhou 6
Amsterdam 5
Kolkata 5
Nanchang 5
Paris 5
Tianjin 5
Cislago 4
Davis 4
Des Moines 4
Fosses 4
Genova 4
Hangzhou 4
Hong Kong 4
Kazan 4
Liverpool 4
Lyon 4
Magdeburg 4
Oulu 4
Santiago 4
Sheffield 4
Shenzhen 4
São Paulo 4
West Roxbury 4
Bedford 3
Bern 3
Buffalo 3
Changchun 3
Changsha 3
Charlottesville 3
Darmstadt 3
Dresden 3
Frankfurt am Main 3
Gif-sur-Yvette 3
Totale 3.897
Nome #
Integrin signalling adaptors: not only figurants in the cancer story 522
β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. 489
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries 262
Modeling ErbB2-p130Cas interaction to design new potential anticancer agents. 229
Cas proteins: dodgy scaffolding in breast cancer. 191
Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells 188
p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy 186
Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion 180
p130Cas promotes invasiveness of three dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1 179
Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines. 159
Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome. 156
Assessing tumor vascularization as a potential biomarker of imatinib resistance in gastrointestinal stromal tumors by dynamic contrast-enhanced magnetic resonance imaging 153
The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma 152
p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells 147
Dbl oncogene expression in MCF-10 A epithelial cells disrupts mammary acinar architecture, induces EMT and angiogenic factor secretion. 143
p130Cas over-expression impairs mammary branching morphogenesis in response to estrogen and EGF 136
Conditional ablation of p130Cas/BCAR1 adaptor protein impairs epidermal homeostasis by altering cell adhesion and differentiation. 131
Mapping of p140Cap Phosphorylation Sites: The EPLYA and EGLYA Motifs Have a Key Role in Tyrosine Phosphorylation and Csk Binding, and Are Substrates of the Abl Kinase 130
Interfering with inflammation: a new strategy to block breast cancer self-renewal and progression? 122
A PKC-eta/Fyn-dependent pathway leading to keratinocyte growth arrest and differentiation. 110
Integrins and Signal Transduction 108
Convergence of integrins and EGF receptor signaling via PI3K/Akt/FoxO pathway in early gene Egr-1 expression 100
Identification of two regions in the p140Cap adaptor protein that retain the ability to suppress tumor cell properties 100
Systematic analysis of the epidermal growth factor receptor by mass spectrometry reveals stimulation-dependent multisite phosphorylation 95
Morgana acts as a proto-oncogene through inhibition of a ROCK-PTEN pathway. 93
P140Cap and P130Cas Adaptor Proteins as Molecular Hubs in Cell Migration and Invasion 92
p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity 88
STAT5 activation induced by diabetic LDL depends on LDL glycation and occurs via src kinase activity. 85
p130Cas/BCAR1 scaffold protein in tissue homeostasis and pathogenesis 85
The adaptor proteins p140CAP and p130CAS as molecular hubs in cell migration and invasion of cancer cells. 84
Defining the role of the adaptor protein p130Cas in mammary normal and cancer stem/progenitor cells 82
Negative regulation of cell growth and differentiation by TSG101 through association with p21(Cip1/WAF1). 78
p130Cas is an essential transducer element in ErbB2 transformation 76
Integrin regulation of epidermal growth factor (EGF) receptor and of EGF-dependent responses 76
p130Cas: a versatile scaffold in signaling networks 74
Differential onset of expression of alpha 7 and beta 1D integrins during mouse heart and skeletal muscle development 74
p130Cas and p140Cap the bad and the good guys in breast cancer cell progression to an invasive phenotype 73
p140Cap dual regulation of E-cadherin/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation 71
P130Cas-associated protein (p140Cap) as a new tyrosine-phosphorylated protein involved in cell spreading 69
GENOTOXIC TESTING"Regolazione dell'espressione della proteina p130Cas nei tumori" 68
Nuclear Akt2 opposes limbal keratinocyte stem cell self-renewal by repressing a FOXO-mTORC1 signaling pathway. 67
p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene–dependent breast tumorigenesis 66
p130Cas Alters the Differentiation Potential of Mammary Luminal Progenitors by Deregulating C-Kit Activity. 65
p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells 64
The essence of integrin signal transduction. Assembly od dynamic scaffolds and cross-talk with other receptors 61
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents (Scientific Reports, (2019), 9, 1, (3089), 10.1038/s41598-019-39510-w) 61
Tyrosine phosphorylation and src family kinases control keratinocyte cell-cell adhesion. 60
Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis 54
Quantitation of multisite EGF receptor phosphorylation using mass spectrometry and a novel normalization approach 53
p130Cas/ BCAR1 and p140Cap/ SRCIN1 Adaptors: The Yin Yang in Breast Cancer? 52
Totale 6.239
Categoria #
all - tutte 14.899
article - articoli 0
book - libri 0
conference - conferenze 242
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.141


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019272 0 0 0 0 0 0 0 0 0 0 193 79
2019/20201.045 61 48 65 107 78 125 137 99 119 99 58 49
2020/2021851 57 92 71 48 123 43 71 48 76 88 47 87
2021/2022890 52 36 42 89 55 25 80 67 24 75 162 183
2022/20231.191 127 129 49 146 91 265 74 49 147 31 52 31
2023/2024391 40 89 35 24 42 67 16 38 6 22 12 0
Totale 6.239